Amiodarone Structural Formula (Image 02)
Amiodarone Hydrochloride Injection, Solution
Product Images NDC 70436-232
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amiodarone Hydrochloride (NDC 70436-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
70436-232-72 (Image 1)
70436-232-73 (Image 2)
This text provides information on an injectable medication called Amiodarone Hydrochloride in a 9mL single-dose vial for intravenous use only. It emphasizes the importance of dilution before administration. The product details such as strength (50mg/mL), dosage instructions, temperature conditions, handling precautions, and manufacturer information are also mentioned. It is advised to refer to the accompanying prescribing information for complete instructions.*
70436-232-74 (Image 3)
This text provides details for an Amiodarone Hydrochloride injection in an 18ml single-dose vial. The medication is used intravenously and must be diluted before use. It contains Amiodarone Hydrochloride, polysorbate 80, benzyl alcohol, and water for injection. The usual dosage instructions are provided separately. The product should be stored at 20°to 25°C (68° to 77°F) and protected from light and excessive heat. The manufacturer is Slate Run Pharmaceuticals, LLC based in Columbus, Ohio, and it is manufactured by Zhejiang Poly Pharm. Co. Ltd in Hangzhou, Zhejiang, China.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
